We analyzed the associations between the polymorphisms in the IL-17A and IL-17F genes and a series of clinicopathologic features, including clinical stage, lymph node metastasis, tumor size, and the statuses of P53, ER, PR, Her-2 and TNBC. This evidence concerns the gene TP53 and metastatic malignant neoplasm in the lymph nodes.